Streetbeat News

Products Services

RSLS

ReShape Lifesciences has received a Notice of Allowance for its US patent application titled 'Intragastric Volume-Occupying Device And Method For Fabricating Same' aimed at treating obesity.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 4:58 pm

TWLO

Twilio has confirmed that hackers abused its API to verify millions of Authy MFA phone numbers, raising concerns about the security of its services.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 4:50 pm

MA

V

Mastercard and Ant Group have expanded their International Consumer Friendly Zones program to Chengdu and Chongqing in Western China, in response to increased inbound travel and international tourism. This initiative will enhance digital payment visibility and options in over 60 primary shopping districts, tourist sites, airports, and railway stations. Spending by international visitors using digital payment methods surged 13 times in the first half of 2024 compared to the previous year.

Portfolio Pulse from Nabaparna Bhattacharya

July 03, 2024 | 4:49 pm

NVO

A new study has found a potential link between Novo Nordisk's GLP-1 drugs, Ozempic and Wegovy, and a serious eye condition called nonarteritic anterior ischemic optic neuropathy (NAION), which can lead to vision loss. The study showed that individuals with diabetes or obesity who were prescribed semaglutide had a significantly higher risk of developing NAION compared to those using non-GLP-1 drugs. However, the study has limitations and does not establish causality.

Portfolio Pulse from Vandana Singh

July 03, 2024 | 4:41 pm

AMC

CMCSA

CNK

DIS

PARA

The upcoming simultaneous release of 'Wicked' and 'Gladiator II' is drawing comparisons to the successful 'Barbenheimer' weekend. Universal's 'Wicked' will now open on Nov. 22, 2024, competing with Paramount's 'Gladiator II'. This could boost ticket sales and benefit movie theater stocks like AMC and Cinemark.

Portfolio Pulse from Chris Katje

July 03, 2024 | 4:41 pm

INSM

Insmed Incorporated shares are trading lower following the announcement of additional results from the ASPEN study of brensocatib in patients with non-cystic fibrosis bronchiectasis.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 4:36 pm

STLA

Stellantis NV (NYSE:STLA) and CEA have announced a five-year collaboration to develop next-generation EV battery cells. The partnership aims to create advanced battery cells with higher performance, longer lifespan, and lower carbon footprint, supporting Stellantis' strategic plan to achieve carbon net zero by 2038.

Portfolio Pulse from Shivani Kumaresan

July 03, 2024 | 4:33 pm

XPEV

XPeng, Inc. (NYSE:XPEV) shares are trading higher after the company reported strong vehicle delivery figures for June and the first half of 2024. XPeng delivered 10,668 Smart EVs in June, a 24% increase year-over-year, and 52,028 Smart EVs in the first half of 2024, a 26% increase from last year. The company also debuted the M03 model in its Mona series. Despite the positive news, analysts have a cautious outlook with an average 12-month price target of $7.65.

Portfolio Pulse from Erica Kollmann

July 03, 2024 | 4:30 pm

KAYS

TCNNF

Trulieve Cannabis Corp. is expanding its retail footprint in Florida amidst growing support for recreational cannabis legalization. The company opened two new medical marijuana shops and plans a ribbon-cutting ceremony for another location. Trulieve has invested heavily in the #YesOn3 ballot initiative. Meanwhile, Kaya Holdings announced the opening of its psilocybin treatment center in Oregon.

Portfolio Pulse from Jelena Martinovic

July 03, 2024 | 4:28 pm

AAPL

INTC

NVDA

TSM

Taiwan Semiconductor Manufacturing Co (TSMC) is expected to see significant growth due to expanding AI demand and advancements in 2nm technology. UBS has given TSMC a 'Buy' rating with a target price of 1,070 yuan, citing strong demand for cloud AI and high-performance computing applications. TSMC's gross profit margin is expected to rise, and its capital expenditure has been revised from $35 billion to $37 billion. TSMC's wafer production capacity is projected to increase significantly by 2025, driven by demand from Nvidia, Intel, and Apple.

Portfolio Pulse from Anusuya Lahiri

July 03, 2024 | 4:27 pm